3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Squamous Cell Carcinoma of Head and Neck
22
Uterine Cervical Neoplasms
19
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Oropharyngeal Neoplasms
14
Ovarian Neoplasms
12
Carcinoma
10
Urinary Bladder Neoplasms
9
Stomach Neoplasms
9
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Fallopian Tube Neoplasms
9
Hypopharyngeal Neoplasms
8
Mesothelioma, Malignant
7
Medulloblastoma
7
Cholangiocarcinoma
7
Breast Neoplasms
7
Adenocarcinoma of Lung
7
Pancreatic Neoplasms
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Gallbladder Neoplasms
6
Ganglioneuroblastoma
5
Brain Neoplasms
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Lymphoid Interstitial Pneumonia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Interventions
Fluorouracil
218
Leucovorin
201
Oxaliplatin
191
Irinotecan
148
Bevacizumab
107
Capecitabine
93
Cetuximab
89
Folfox protocol
54
Chemotherapy, Adjuvant
34
Panitumumab
30
pembrolizumab
23
Nivolumab
22
Colonoscopy
22
Gemcitabine
20
Magnetic Resonance Spectroscopy
19
Floxuridine
19
IFL protocol
18
Celecoxib
18
Radiotherapy
17
Neoadjuvant Therapy
17
Early Intervention, Educational
17
Drug Therapy
17
Laparoscopy
14
Cyclophosphamide
14
Counseling
14
trifluridine tipiracil drug combination
13
regorafenib
13
XELOX
13
Exercise
13
Erlotinib Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Neoplasms
×
Platinum
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled